跳至主要内容
临床试验/TCTR20181204005
TCTR20181204005尚未招募2 期

Effectiveness of oral glucose solution for the treatment of neonatal hypoglycemia, a randomized, placebo-controlled trial

the Siriraj Research Development Fund (Managed by Routine to Research: R2R).0 个研究点目标入组 400 人开始时间: 2018年12月4日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 N/A (No limit) 至 48 Hours(—)
性别
All

入选标准

  • 1. At least 34-week's GA
  • 2. At least 1 risk factor of postnatal hypoglycemia (preterm, maternal diabetes, SGA, LGA, birthweight less than 2500g or more than 4000g)
  • 3. Asymtomatic hypoglycemia
  • 4. Age less than 48 hours
  • 5. No contraindication of oral feedings
  • 6. Parental written consent

排除标准

  • 1. Blood glucose less than 25 mg/dL
  • 2. IV fluid is indicated from other reasons
  • 3. Major anomalies

研究者

发起方
the Siriraj Research Development Fund (Managed by Routine to Research: R2R).

相似试验